NCEL

NewcelX Ltd. NASDAQ Listed Oct 24, 2025

Healthcare ·Biotechnology ·CH · newcelx.com

$3.24

Pre-mkt $3.30 -3.79%

Mkt Cap $1.5M

52w Low $1.83 4.9% of range 52w High $30.80

50d MA $2.85 200d MA $9.08

P/E (TTM) -0.1x

EV/EBITDA 0.0x

P/B 0.2x

Debt/Equity 0.0x

ROE -114.5%

P/FCF -0.4x

RSI (14) —

ATR (14) —

Beta 0.57

50d MA $2.85

200d MA $9.08

Avg Volume 42.6K

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.

SIC Code

2834

CIK (SEC)

1783036

Phone

972 73 797 1600

The Circle 6 · Zurich 8058 · CH

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Oct 4, 2025	AMC	—	-5.54	—	—	—	—	—	—	—	—	—
May 15, 2024	AMC	-8.40	-0.00	+100.0%	58.40	-6.5%	+2.4%	+9.7%	+7.9%	-13.6%	+4.6%	—
Jun 30, 2023	AMC	-6.80	-0.20	+97.1%	440.00	+13.6%	+9.1%	+18.3%	-16.2%	-18.5%	-5.4%	—
May 5, 2023	AMC	-12.00	-0.29	+97.5%	552.00	-2.2%	-2.9%	-6.7%	+1.6%	-3.9%	-14.8%	—

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
Apr 27, 2026	Samuel OlivierDir	—	Buy	81,818	$2.75	$225K	81,818	+28.95%	-7.52%
Apr 27, 2026	Revel MichelDir/Off	CSO and Director	Buy	54,545	$2.75	$150K	957,530	+28.95%	-7.52%

Data updated apr 26, 2026 2:25pm · Source: massive.com